VERTEX PHARMACEUTICALS INC / MA Insider Trading for August 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for August 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 86.52 | 4,659 | 403,097 | 13,980 | |
| Aug 20 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 91.05 | 3,592 | 327,052 | 3,592 | |
| Aug 20 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 131.89 | 4,250 | 560,533 | 0 | |
| Aug 20 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 186.37 | 2,330 | 434,242 | 31,553 | 33.9 K to 31.6 K (-6.88 %) |
| Aug 20 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 186.41 | 2,329 | 434,149 | 33,883 | 36.2 K to 33.9 K (-6.43 %) |
| Aug 20 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 86.52 | 4,659 | 403,097 | 36,212 | 31.6 K to 36.2 K (+14.77 %) |
| Aug 20 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 186.41 | 1,796 | 334,792 | 31,553 | 33.3 K to 31.6 K (-5.39 %) |
| Aug 20 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 186.37 | 1,796 | 334,721 | 33,349 | 35.1 K to 33.3 K (-5.11 %) |
| Aug 20 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 91.05 | 3,592 | 327,052 | 35,145 | 31.6 K to 35.1 K (+11.38 %) |
| Aug 20 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 186.37 | 4,250 | 792,073 | 31,553 | 35.8 K to 31.6 K (-11.87 %) |
| Aug 20 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 131.89 | 4,250 | 560,533 | 35,803 | 31.6 K to 35.8 K (+13.47 %) |
| Aug 15 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 81.54 | 10,000 | 815,400 | 0 | |
| Aug 15 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 81.54 | 10,000 | 815,400 | 0 | |
| Aug 15 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 185.00 | 10,000 | 1,850,000 | 4,124 | 14.1 K to 4.1 K (-70.80 %) |
| Aug 15 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 185.00 | 10,000 | 1,850,000 | 4,124 | 14.1 K to 4.1 K (-70.80 %) |
| Aug 15 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 81.54 | 10,000 | 815,400 | 14,124 | 4.1 K to 14.1 K (+242.48 %) |
| Aug 15 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 81.54 | 10,000 | 815,400 | 14,124 | 4.1 K to 14.1 K (+242.48 %) |
| Aug 12 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 131.89 | 2,125 | 280,266 | 0 | |
| Aug 12 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 181.89 | 2,125 | 386,516 | 33,240 | 35.4 K to 33.2 K (-6.01 %) |
| Aug 12 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 131.89 | 2,125 | 280,266 | 35,365 | 33.2 K to 35.4 K (+6.39 %) |
| Aug 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | M | 86.52 | 2,330 | 201,592 | 13,980 | |
| Aug 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 175.51 | 1,630 | 286,081 | 35,003 | 36.6 K to 35 K (-4.45 %) |
| Aug 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 174.74 | 700 | 122,318 | 36,633 | 37.3 K to 36.6 K (-1.88 %) |
| Aug 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Buy | M | 86.52 | 2,330 | 201,592 | 37,333 | 35 K to 37.3 K (+6.66 %) |
| Aug 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 86.52 | 1,553 | 134,366 | 9,320 | |
| Aug 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 91.05 | 2,155 | 196,213 | 4,311 | |
| Aug 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 176.44 | 1,553 | 274,011 | 32,240 | 33.8 K to 32.2 K (-4.60 %) |
| Aug 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 86.52 | 1,553 | 134,366 | 33,793 | 32.2 K to 33.8 K (+4.82 %) |
| Aug 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 177.78 | 2,155 | 383,116 | 32,240 | 34.4 K to 32.2 K (-6.27 %) |
| Aug 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 91.05 | 2,155 | 196,213 | 34,395 | 32.2 K to 34.4 K (+6.68 %) |